AbbVie introduces Produodopa for advanced Parkinson’s in EU

AbbVie introduces Produodopa for advanced Parkinson’s in EU

Source: 
Pharmaceutical Business Review
snippet: 

AbbVie has announced the launch of Produodopa (foslevodopa/foscarbidopa), a new treatment for advanced Parkinson's disease (PD) patients in the European Union.